These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 38796273)

  • 1. Using Guidelines of Care to Lower Cardiovascular Risk in Patients with Psoriasis.
    Song WB; Soffer DE; Gelfand JM
    Dermatol Clin; 2024 Jul; 42(3):417-428. PubMed ID: 38796273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular health for patients with psoriasis: a précis for front-line clinicians.
    Federman DG; Shelling ML; Prodanovich S; Gunderson CG; Kirsner RS
    Ostomy Wound Manage; 2009 May; 55(5):38-47. PubMed ID: 19471047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psoriasis: a skin disease associated with increased cardiovascular risk.
    González-Gay MA; González-Vela C; González-Juanatey C
    Actas Dermosifiliogr; 2012 Sep; 103(7):595-8. PubMed ID: 22465257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psoriasis and Cardiovascular Disease.
    Shahwan KT; Kimball AB
    Med Clin North Am; 2015 Nov; 99(6):1227-42. PubMed ID: 26476250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular Considerations and Implications for Treatment in Psoriasis: An Updated Review.
    Mehta H; Narang T; Dogra S; Handa S; Hatwal J; Batta A
    Vasc Health Risk Manag; 2024; 20():215-229. PubMed ID: 38745849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular morbidity in psoriasis: epidemiology, pathomechanisms, and clinical consequences.
    Boehncke WH; Boehncke S
    G Ital Dermatol Venereol; 2008 Oct; 143(5):307-13. PubMed ID: 18833072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of cardiovascular disorders in psoriasis patients: current and future.
    Tablazon IL; Al-Dabagh A; Davis SA; Feldman SR
    Am J Clin Dermatol; 2013 Feb; 14(1):1-7. PubMed ID: 23329076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The positive impact of the new National Institute for Health and Care Excellence lipid guidelines on cardiovascular disease risk management in patients with psoriasis.
    Kaur S; Shipman AR; Shipman KE
    Br J Dermatol; 2015 Nov; 173(5):1327-8. PubMed ID: 26075593
    [No Abstract]   [Full Text] [Related]  

  • 9. Are patients with psoriasis being screened for cardiovascular risk factors? A study of screening practices and awareness among primary care physicians and cardiologists.
    Parsi KK; Brezinski EA; Lin TC; Li CS; Armstrong AW
    J Am Acad Dermatol; 2012 Sep; 67(3):357-62. PubMed ID: 22079041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of cardiovascular disease in patients with psoriasis.
    Egeberg A; Skov L
    Expert Opin Pharmacother; 2016 Aug; 17(11):1509-16. PubMed ID: 27192114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.
    Kones R
    Vasc Health Risk Manag; 2013; 9():617-70. PubMed ID: 24174878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practical Guidelines for Managing Patients With Psoriasis on Biologics: An Update.
    Poelman SM; Keeling CP; Metelitsa AI
    J Cutan Med Surg; 2019; 23(1_suppl):3S-12S. PubMed ID: 30789012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Patients with psoriasis have an increased risk of cardiovascular diseases].
    Ahlehoff O; Gislason G; Lindhardsen J; Skov L; Hansen PR
    Ugeskr Laeger; 2012 May; 174(21):1450-2. PubMed ID: 22640784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Research gaps in psoriasis: opportunities for future studies.
    Ryan C; Korman NJ; Gelfand JM; Lim HW; Elmets CA; Feldman SR; Gottlieb AB; Koo JY; Lebwohl M; Leonardi CL; Van Voorhees AS; Bhushan R; Menter A
    J Am Acad Dermatol; 2014 Jan; 70(1):146-67. PubMed ID: 24126079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review.
    Horreau C; Pouplard C; Brenaut E; Barnetche T; Misery L; Cribier B; Jullien D; Aractingi S; Aubin F; Joly P; Le Maître M; Ortonne JP; Paul C; Richard MA
    J Eur Acad Dermatol Venereol; 2013 Aug; 27 Suppl 3():12-29. PubMed ID: 23845149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should all patients with psoriasis receive statins? Analysis according to different strategies.
    Masson W; Lobo M; Molinero G; Rossi E
    An Bras Dermatol; 2019; 94(6):691-697. PubMed ID: 31789271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GRAPPA 2013 basic/translational/clinical science update: comorbidity monitoring.
    Boehncke WH
    J Rheumatol; 2014 Jun; 41(6):1224-6. PubMed ID: 24882857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular mortality in psoriasis and psoriatic arthritis: epidemiology, pathomechanisms, therapeutic implications, and perspectives.
    Boehncke WH; Boehncke S
    Curr Rheumatol Rep; 2012 Aug; 14(4):343-8. PubMed ID: 22562431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of Specialist and Patient Perspectives on Strategies to Improve Cardiovascular Disease Prevention Among Persons With Psoriatic Disease.
    Barbieri JS; Beidas RS; Gondo GC; Fishman J; Williams NJ; Armstrong AW; Ogdie AR; Mehta N; Gelfand JM
    JAMA Dermatol; 2022 Mar; 158(3):252-259. PubMed ID: 35044419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psoriasis as an Independent Risk Factor for Cardiovascular Disease: An Epidemiologic Analysis Using a National Database.
    Lai YC; Yew YW
    J Cutan Med Surg; 2016 Jul; 20(4):327-33. PubMed ID: 26316538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.